Immunohistochemical Abnormalities of Fibrillin in Cardiovascular Tissues in Marfan’s Syndrome
Open Access
- 1 April 1997
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 63 (4) , 1012-1017
- https://doi.org/10.1016/s0003-4975(97)00061-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The spectrum of cardiovascular disease in the Marfan syndrome: A clinico-morphologic study of 18 necropsy patients and comparison to 151 previously reported necropsy patientsPublished by Elsevier ,2004
- Composite Graft Repair of Marfan Aneurysm of the Ascending Aorta: Results in 150 PatientsJournal of Cardiac Surgery, 1994
- Progression of Aortic Dilatation and the Benefit of Long-Term β-Adrenergic Blockade in Marfan's SyndromeNew England Journal of Medicine, 1994
- Genetic Linkage of the Marfan Syndrome, Ectopia Lentis, and Congenital Contractural Arachnodactyly to the Fibrillin Genes on Chromosomes 15 and 5New England Journal of Medicine, 1992
- Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin geneNature, 1991
- Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils.The Journal of cell biology, 1986
- Elastin-Associated Microfibrils and Microfibrillar ProteinsPublished by Elsevier ,1983
- The Marfan Syndrome: Diagnosis and ManagementNew England Journal of Medicine, 1979
- Life Expectancy and Causes of Death in the Marfan SyndromeNew England Journal of Medicine, 1972
- A technique for complete replacement of the ascending aortaThorax, 1968